ESMO 2024 Insights: GORTEC 2017-01 REACH Trial - Avelumab-Cetuximab-RT vs. Standards of Care in Patients With Locally Advanced SCC of Head & Neck

8 views
September 23, 2024
0 Comments
Login to view comments. Click here to Login